Back

Wellcome Leap adds John Young and Thomas Glanzmann to board

Verifying
  • Wellcome Leap appointed John Young and Thomas Glanzmann to its Board of Directors.
  • 35 years at Pfizer shaped Young’s leadership across commercial operations, strategy and business development.
  • Richard Gillingwater said both directors bring experience turning scientific advances into real-world impact.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.